I’ll be attending a conference on Friday October 27th at the UW Law School: Psychedelic Medicine – New Frontiers in Palliative Care. The use of psilocybin, MDMA, marijuana and others will be discussed particularly in relation to palliative and end-of-life care. There are thorny legal and regulatory issues as you might expect. Perhaps though we can help alleviate severe PTSD and uncontrolled anxiety with this “new” approach.
From BerkleyWellness: “The Aztecs and Timothy Leary touted the psychological benefits of mind-altering psychedelic drugs. Now, science is finding out they may have been right.
“Researchers are investigating the use of the mind-altering drugs psilocybin, for depression associated with advanced cancer, and MDMA, for post-traumatic stress disorder (PTSD). These drugs may also prove to be useful for other treatment-resistant psychiatric conditions. In fact, the entire December 2016 issue of the Journal of Psychopharmacology was devoted to the clinical utility of psychedelic drugs.”
Please do come back, Jim, and tell us what you learned!!!